Patients in specific vulnerable population groups suffer disproportionately from cancer. The
elimination of cancer disparities is critically important for lessening the burden of cancer. The …

Cancer is now recognized as one of the four leading causes of morbidity and mortality
worldwide, and incidence is expected to rise significantly in the next two decades …

The American Society of Clinical Oncology (ASCO) has embarked on an intensive campaign
to integrate elimination of cancer health disparities into the Society's overall mission and …

Purpose Guidelines recommend sentinel lymph node biopsy (SLNB) for patients with clinical
stage IB/II melanomas, but not clinical stage IA melanoma. This study examines factors …

BACKGROUND There are significant disparities in cancer outcomes between Indigenous
and non‐Indigenous Australians. Identifying the unmet supportive care needs of Indigenous …

Objective: The prognoses of gastric cancer patients vary greatly among countries.
Meanwhile, tumor-node-metastasis (TNM) staging system shows limited accuracy in …

The incidence of breast cancer in Latin American countries is lower than that in more
developed countries, whereas the mortality rate is higher. These differences probably are …

In the next 20 years, it is expected that 70% of incident cancers will be diagnosed in the
developing world. There exist very few models of cancer care delivery in resource …

BACKGROUND: The BCRF II study presents a systematic review of the norms,
recommendations and guidelines that are considered medical care standards (MCS) for …

Introduction There is a lack information regarding how sentinel lymph node biopsy (SLNB)
for breast cancer is carried out today in developing countries and how it was adapted. To …